Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00622661 · ClinicalTrials.gov registry record · NA

Carbohydrates and Related Biomarkers

A NA study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
89
Enrollment target

NCT00622661 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 89 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00622661, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
89 participants
Enrollment target

Study Summary

This study is designed to investigate associations of low- and high-glycemic load diets with biomarkers of hyperglycemia, hyperinsulinemia and inflammation, potential biomarkers for cancer risk.

Interventions

  • OTHER Low Glycemic Load Diet
  • OTHER High Glycemic Load Diet

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2006-06
Est. Completion 2010-07
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT00622661

The ClinicalTrials.gov registry entry for NCT00622661 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Low Glycemic Load Diet is the first listed.

NCT00622661 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00622661 about?

NCT00622661 is a clinical study titled "Carbohydrates and Related Biomarkers". This study is designed to investigate associations of low- and high-glycemic load diets with biomarkers of hyperglycemia, hyperinsulinemia and inflammation, potential biomarkers for cancer risk.

What is the current status of trial NCT00622661?

This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2006-06. Estimated completion is 2010-07.

What interventions are being tested in trial NCT00622661?

The interventions under investigation include: Low Glycemic Load Diet (OTHER), High Glycemic Load Diet (OTHER).

Who is sponsoring clinical trial NCT00622661?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.